| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0527-4107-37 | 0527-4107 | HUMAN PRESCRIPTION DRUG | Mexiletine Hydrochloride | Mexiletine Hydrochloride | CAPSULE | ORAL | 20200723 | N/A | ANDA | ANDA213500 | Lannett Company, Inc. | MEXILETINE HYDROCHLORIDE | 150 mg/1 | 100 CAPSULE in 1 BOTTLE (0527-4107-37) |
| 0527-4109-37 | 0527-4109 | HUMAN PRESCRIPTION DRUG | Mexiletine Hydrochloride | Mexiletine Hydrochloride | CAPSULE | ORAL | 20200723 | N/A | ANDA | ANDA213500 | Lannett Company, Inc. | MEXILETINE HYDROCHLORIDE | 250 mg/1 | 100 CAPSULE in 1 BOTTLE (0527-4109-37) |
| 0527-4108-37 | 0527-4108 | HUMAN PRESCRIPTION DRUG | Mexiletine Hydrochloride | Mexiletine Hydrochloride | CAPSULE | ORAL | 20200723 | N/A | ANDA | ANDA213500 | Lannett Company, Inc. | MEXILETINE HYDROCHLORIDE | 200 mg/1 | 100 CAPSULE in 1 BOTTLE (0527-4108-37) |
| 62135-785-90 | 62135-785 | HUMAN PRESCRIPTION DRUG | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE | ORAL | 20231025 | N/A | ANDA | ANDA213500 | Chartwell RX, LLC | MEXILETINE HYDROCHLORIDE | 250 mg/1 | 90 CAPSULE in 1 BOTTLE (62135-785-90) |